DDD

3D SYSTEMS CORP

Technology | Small Cap

-$0.07

EPS Forecast

$98.98

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

3D Systems Q2 2026 Earnings: Healthcare Gains Illuminate a Portfolio in Flux

DDD (NYSE: DDD) reported its second‑quarter 2026 results, delivering revenue of $94.6 million, a 0.3% dip year over year (1.4% growth excluding divestitures). The quarter produced a net loss of $12.9 million and a negative Adjusted EBITDA of $0.8 million. The press release highlights strength in Healthcare—where Med Tech and Dental posted growth—while Industrial revenue declined, underscoring a bifurcated business that still relies on cost discipline to prop up profitability. Notably, the release does not provide an EPS figure in this excerpt, and EPS consensus among analysts remains a watch item as investors parse the impact of pricing, mix, and non‑recurring cost actions. There was no obvious earnings surprise relative to expectations, and the company did not issue a new revenue forecast beyond the reported quarterly results.

Executive snapshot

  • Revenue: $94.6 million for the quarter; down 0.3% YoY, up 1.4% excluding divestitures.
  • Net income / EPS implications: Net loss of $12.9 million; EPS implications are not disclosed in this excerpt.
  • Adjusted EBITDA: Loss of $0.8 million for the quarter; first half of 2026 shows a net loss of $17.3 million but positive Adjusted EBITDA of $1.3 million.
  • Segment momentum: Healthcare remains the largest segment with 6.8% YoY revenue growth; Industrial revenue declined 6.7% YoY (3.7% excluding divestitures) but rose 2.4% sequentially.
  • Strategic growth vectors: Four priority markets delivered more than 20% growth in H1 2026: Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure.

Segment-level color

The healthcare franchise carried the quarter, with revenue momentum aided by notable pushes in Med Tech and Dental. That said, the company’s competitive narrative remains tied to prints and systems, not just consumables; the growth in healthcare hints at a durable demand for higher‑value printers and applications.

Industrial revenue continued to sag year over year, a reminder that the transition toward higher‑value, higher‑margin platforms can be lumpy. Within Industrial, Aerospace & Defense and Data Center Infrastructure delivered upside—more than offsetting softness elsewhere—hinting at a more diversified industrial demand palette than in the CEO’s quarterly soap opera of prior years.

The four pivot markets

The first half of 2026 underscored a strategic thesis: growth is not broad, but highly concentrated in select verticals. Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure each posted double‑digit growth, reinforcing the company’s plan to tilt its portfolio toward end markets with higher willingness to invest in sophisticated additive manufacturing solutions. If these segments can sustain acceleration, the earnings trajectory could tilt toward a more favorable mix, even amid near‑term headwinds in other lines of business.

Unaudited snapshot: a taste of the numbers

The company’s quarterly and six‑month figures were presented in a detailed table, with revenue broken out for June 30, 2026 and June 30, 2025, and the six‑month comparatives. The headline takeaways are consistent with the narrative above: revenue of roughly $95 million in Q2, a net loss that underscored ongoing cost discipline, and a modest positive Adjusted EBITDA in the first half when viewed on a cumulative basis.

Implications for DDD and the peer group

This quarter reads as a calibration: the company can still generate meaningful top‑line progress in high‑growth healthcare verticals, but profitability hinges on cost control and the ability to extract value from a more selective product mix. For peers in the 3D printing and manufacturing‑class tech space, the message is less about a dramatic reacceleration and more about a strategic reallocation of R&D and sales effort toward sectors with higher willingness to invest in advanced systems.

Analysts watching EPS consensus will note that a negative net income backdrop can compress near‑term multiple leverage, even as long‑term price-to-value propositions hinge on recurring software/maintenance revenue and higher‑margin hardware cycles. In other words, the “revenue forecast” game remains important, but the stock’s directional risk will be driven by how well the company can convert growth in Med Tech, Dental, and Defense into sustainable margin expansion.

Takeaway

3D Systems’ Q2 2026 results reinforce a nuanced narrative: growth exists, but profitability remains tethered to disciplined cost management and a favorable mix shift toward higher‑growth, higher‑value markets. The absence of an explicit EPS figure in the press release means investors will be scanning the upcoming filings and conference calls for clarity on EPS trajectories and how the company’s cost actions translate into shareholder value. For now, the ticker DDD sits at an inflection point where the healthcare growth engine dominates the next leg of the story, while the industrial engine must prove it can regain momentum without sacrificing the core cost discipline that lifts the overall profitability profile. In the sector, a similar mix of growth persistence and margin discipline could set a template for the rest of the year.

Note: This analysis converts the EX-99.1 filing data into a narrative for investors. Numbers reflect the quarter ended June 30, 2026 and the first six months of 2026 as disclosed in the release. Ticker: DDD;EPS;EPS consensus;earnings surprise;revenue forecast;revenue;net loss;Adjusted EBITDA;Healthcare;Industrial;Med Tech;Aerospace & Defense;Data Center Infrastructure.